J.P. Morgan Day Four: Talking With Execs About BD Plans
Interviews With Lilly, Roche, Takeda And More
Daily notebook from the J.P. Morgan Healthcare Conference: Big pharma execs weigh in on business development strategy, Sage CEO Barry Green discusses how the Inflation Reduction Act should spur deal-making and bluebird talks about gene therapy commercialization plans.
